GlassScriptPhysician profile
Desarom Teso
NPI 1558579565
$4,477.46
in general payments reported to CMS, 2019-2025
20 companies · $1,036 in 2025
The $1,036 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,281 · 2020: $75.67 · 2021: $249 · 2022: $83.18 · 2023: $399 · 2024: $353 · 2025: $1,036.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,124 · Travel and Lodging: $664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,124.40 |
| Travel and Lodging | $664.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,923.15 | 2019 | |
| W. L. Gore & Associates, INC. | $1,029.67 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, C3 Delivery System |
| Lemaitre Vascular, INC. | $405.62 | 2024-2025 | Hydro Lemaitre Valvulotome, Artegraft Vascular Graft, Trivex System |
| Medtronic, INC. | $336.79 | 2021-2025 | Endurant Iis, Venaseal |
| Abbott Laboratories | $136.07 | 2021 | |
| Janssen Pharmaceuticals, INC | $103.82 | 2019-2022 | |
| Boston Scientific Corporation | $98.14 | 2019-2020 | |
| Silk Road Medical, INC. | $78.50 | 2021-2022 | |
| Cook Medical LLC | $71.34 | 2019-2024 | Zilver Ptx |
| E.R. Squibb & Sons, L.L.C. | $57.11 | 2019-2020 | |
| Philips North America LLC | $53.28 | 2019-2024 | (Br5) Peripheral Ivus |
| Cardiovascular Systems INC. | $45.25 | 2019-2020 | |
| Amgen INC. | $43.98 | 2019 | |
| Smith+Nephew, INC. | $20.56 | 2021 | |
| Organogenesis INC. | $16.78 | 2025 | Puraply Wound Matrix |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $16.00 | 2023 | Flexitouch Plus, Entre Plus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.41 | 2019 | |
| Haemonetics Corporation | $13.70 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $12.29 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Desarom Teso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.